ctDNA MRD test clinical trials

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

This study looks at a new way to find small amounts of breast cancer DNA in the blood after treatment. It aims to see if this test can help predict how well high-risk breast cancer patients do over time after chemotherapy.